TNFRSF9 and infection: Here, we show that treatment of mice with an agonist antibody to 4-1BB strongly promotes the expansion and accumulation of virus-specific primary effector CD8 T cells during infection with live virulent and attenuated VACV or with an immunization strategy with VACV peptides.